Laboratorios Farmaceuticos Rovi, S.A.
LABFFOTCHealthcare● Active
$90.61
+$0.00(+0.00%)
Market Cap$4.6B
P/E Ratio—
52W High$90.61
52W Low$90.61
Laboratorios Farmaceuticos Rovi, S.A. (LABFF) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · LABFF · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.10B | $0.03B | $0.03B | $0.12B | $0.10B |
| Net Receivables | $0.18B | $0.14B | $0.12B | $0.16B | $0.13B |
| Inventory | $0.29B | $0.33B | $0.34B | $0.31B | $0.25B |
| Total Current Assets | $0.57B | $0.49B | $0.51B | $0.62B | $0.51B |
| PP&E Net | $0.33B | $0.29B | $0.25B | $0.22B | $0.18B |
| Goodwill | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Intangible Assets | $0.03B | $0.03B | $0.03B | $0.04B | $0.04B |
| Total Assets | $0.96B | $0.83B | $0.80B | $0.88B | $0.73B |
| Liabilities | |||||
| Short-Term Debt | $0.04B | $0.02B | $0.01B | $0.01B | $0.00B |
| Accounts Payable | $0.07B | $0.09B | $0.11B | $0.13B | $0.10B |
| Total Current Liabilities | $0.18B | $0.16B | $0.20B | $0.29B | $0.19B |
| Long-Term Debt | $0.09B | $0.08B | $0.04B | $0.05B | $0.05B |
| Total Liabilities | $0.28B | $0.25B | $0.26B | $0.36B | $0.26B |
| Stockholders Equity | |||||
| Retained Earnings | $0.58B | $0.49B | $0.56B | $0.46B | $0.45B |
| Total Stockholders Equity | $0.66B | $0.57B | $0.54B | $0.52B | $0.47B |
| Total Liab & Equity(computed) | $0.94B | $0.82B | $0.80B | $0.88B | $0.73B |
| Debt Summary | |||||
| Total Debt | $0.15B | $0.11B | $0.07B | $0.07B | $0.07B |
| Net Debt | $0.05B | $0.09B | $0.04B | ($0.05B) | ($0.03B) |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · EUR · B
Explore more Laboratorios Farmaceuticos Rovi, S.A. data
About Laboratorios Farmaceuticos Rovi, S.A. (LABFF) Balance Sheet
Laboratorios Farmaceuticos Rovi, S.A. (LABFF) balance sheet shows total assets of $0.96B with cash of $0.10B. Total liabilities are $0.28B, total debt $0.15B, and stockholders equity $0.66B.
Frequently asked questions
LABFF · 4 questionsLaboratorios Farmaceuticos Rovi, S.A. has total debt of $0.15B with net debt of $0.05B.
LABFF total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10